Loading…
Orphan Earmarks Act of 2011
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
8d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2012 · fourth_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues, medical device tax issues, and corporate tax issues.
Client expense: Not reported · Firm income: $40,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $60,000
Government targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $70,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $60,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $80,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $80,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $70,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Defense
Support defense and homeland security authorization and appropriations legislation relating to the development of technologies for use against biological and chemical contamination--Congressional contacts on FDA issues in HR 633, contacts with FDA on regulatory issues
Client expense: Not reported · Firm income: $70,000
Government targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE